-
Pain and Non-Motor Symptoms in FXTAS
-
Pain and symptom management in a case of cervical dystonia with comorbid generalized joint hypermobility using prolotherapy with osteopathic manipulative medicine
-
Pain in cervical dystonia: A meta-analysis of outcomes following treatment with abobotulinumtoxinA in randomized, controlled clinical studies
-
Palliative care evaluation for movement disorders during COVID-19: Using Tele neurology to provide real-time care for an at risk Veterans Population.
-
Pallidal deep brain stimulation alters reward learning in segmental dystonia: a pilot study
-
Pallidal deep brain stimulation entrains finely tuned gamma oscillations in motor cortex
-
Pallidal recordings in fully implanted dystonic patients: preliminary results
-
Pallidal single unit activity in cervical dystonia patients with unilateral deep brain stimulation
-
Pallidal Stimulation in children with monogenic dystonia
-
Paradoxical cerebral hyperperfusion in Parkinson’s disease with orthostatic hypotension
-
PARK-BAND training program for Parkinson’s disease in clinical settings: A feasibility study.
-
ParkAI – An AI Based Tool for Detection of Parkinson’s Disease using Vocal Measurements
-
Parkin Mutation and Deep Brain Stimulation
-
Parkinson Disease with, but not without, Cognitive Decline Reveals Advanced Brain Aging
-
Parkinson Progression Marker Initiative – New Science/New Cohorts
-
PARKINSON’S DISEASE AND COVID-19 PANDEMIC: MODIFICATIONS IN MOTOR AND NON-MOTOR SYMPTOMS AND IN THE ACCESS TO MEDICAL AND NON-MEDICAL CONSULTATIONS AND TREATMENTS
-
Parkinson’s Families Project: analysis of a large cohort of patients with early onset and familial Parkinson’s disease
-
Parkinson’s rest tremor disappearance after cerebellar hemorrhage
-
Parkinson’s disease and Post-COVID-19 syndrome
-
Parkinson’s Disease Clinical Progression in Latino Patients
-
Parkinson’s Disease Functional Impacts Digital Instrument (PD-FIDI): Studies Preceding Clinical Validation
-
Parkinson’s Disease Medication Safety in the Inpatient Cohort of a Tertiary Centre
-
Parkinson’s disease patients may be at higher risk of Covid-19 mortality
-
Parkinson’s disease patients with hallucinations exhibit dopaminergic degeneration and cortical thinning
-
Parkinson’s disease-linked LDL Receptor Related Protein 10 (LRP10) is implicated in regulation of the secretory and autophagy-lysosome pathways
-
Parkinson’s Disease, Cognitive Function and Health Literacy: A Problem with Shared Decision Making
-
Parkinson’s Disease, Cognitive Function and Medication Management: A Problem in Routine Care
-
Parkinson’s Disease, Cognitive Function: Exploration of the Relation of Multi-Domain Computerized Cognitive Testing and IADL (instrumental activities of daily living) and Neuro-QoL Upper Extremity Function (Fine Motor, ADL)
-
Parkinson’s-disease risk variants are differentially associated with discrete phenotypic characteristics of Parkinson’s-disease at baseline.
-
Parkinsonism in a patient with limbic-predominant age-related TDP-43 encephalopathy (LATE) syndrome
-
Parkinsonism in individuals with genetic neurodevelopmental disorders: A systematic review
-
Pathway to Parkinson’s Exercise Education Accreditation: Competencies for Exercise Professionals and Exercise Education Programs
-
Patient and Care Partner Perspectives on a Community-Based Outpatient Palliative Care Intervention for Parkinson’s Disease and Related Disorders
-
Patient classification for adaptive deep brain stimulation
-
Patient-Reported Impact of Standard-of-Care: Change in Symptoms Following Dopamine Initiation and Deep Brain Stimulation
-
Patterns and determinants of healthcare utilization among people with Parkinson’s disease: A population based analysis in Ontario, Canada
-
Patterns of Cortical Thinning in Patients with Parkinson’s Disease
-
Patterns of Improvement with Valbenazine in Patients with Tardive Dyskinesia
-
PD phenotype with premotor RBD is associated with a dysbiotic profile of gut microbiota.
-
People living with Parkinson’s disease during the COVID-19 Pandemic: A cross-sectional survey of the Canadian experience
-
Perampanel as a treatment for Orthostatic Tremor
-
Perampanel inhibits α-synuclein transmission in Parkinson’s disease models
-
PERCEPTION OF INDIVIDUALS WITH PARKINSON´S DISEASE ABOUT ISOLATION DURING THE COVID-19 PANDEMIC
-
Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson’s disease
-
Peripheral neuromodulation for the treatment of bladder symptoms associated with Parkinson’s disease
-
Perivascular spaces in the basal ganglia and long-term motor prognosis in newly diagnosed Parkinson’s disease
-
Persistent and efficient transduction of the putamen following gene therapy for aromatic L-amino acid decarboxylase deficiency
-
Personality dimensions could be predictive of quality-of-life outcome after deep brain stimulation of the sub-thalamic nucleus in Parkinson’s Disease
-
Perspectives of People with Parkinson Disease Managing Exercise during the COVID-19 Pandemic: A Qualitative Study
-
Pharmacokinetic–pharmacodynamics of levodopa/carbidopa following subcutaneous infusion with ND0612: Results from the BeyoND pharmacokinetic substudy
-
Phase 1/2 Open-label Dose Evaluation Study of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease: Efficacy, Safety, and Tolerability Data from the Second Cohort at 6 Months
-
Phenotype characteristics of ANO10 mutation carries: a case series from Serbia and a systematic review of the literature
-
Phenotype-genotype correlation in a case series from South Spain of Hereditary Spastic Paraplegia 7 (SPG7)
-
Physical activity (PA), patient reported outcomes and quality of life in Parkinson’s disease( PD)
-
Physical activity and cognitive functions in individuals with Parkinson’s disease
-
Physical activity and subjective perception of PD symptoms during COVID-19 lockdown: a clinical audit
-
PHYSICAL ACTIVITY AT HOME IS ABLE TO REDUCE THE WORSENING IN QUALITY OF LIFE IN PARKINSON’S DISEASE DURING COVID-19 PANDEMIC
-
Physical and mental fatigue in Parkinson’s Disease: analysis from COPPADIS database
-
Piecing Together the Gut Microbiome in Parkinson’s Disease: A Meta-Analysis
-
Pilot study of Phenotype of Antisense-Oligonucleotide-(ASO)-knockdown of Cerebral-Dopamine-Neurotrophic-Factor (CDNF) as Parkinson Disease model : implications for PD and related Dementia Therapeutics
-
Pilot study to assess gait-related motor symptoms in Parkinson’s disease by using a unique passive monitoring wearable technology
-
Pilot study to evaluate pimavanserin for the treatment of motor and behavioral symptoms of Tourette syndrome.
-
PKG for the management of advance Parkinson’s Disease
-
PLA2G6-Associated Neurodegeneration: A Continuum of Phenotypes
-
Plasma and fecal short chain fatty acids as predictors for the risk and severity of Parkinson’s Disease
-
Plasma microRNA expression profiling in patients with progressive supranuclear palsy. A five-microRNA panel in plasma was identified as a potential biomarker for progressive supranuclear palsy
-
Plasma Neurofilament Light Chain Level and Orthostatic Hypotension in Early Parkinson Disease
-
Plasma phosphorylated α-synuclein relates to cognitive impairment in patients with Parkinson’s disease
-
Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson’s Disease
-
Pooled efficacy and safety analysis of incobotulinumtoxinA for upper- and lower-limb spasticity in children with severe cerebral palsy (GMFCS levels IV–V)
-
Positive effect of Medical Cannabis in adults with Tourette syndrome
-
Post-Covid-19 Parkinson’s disease: a Brazilian case series.
-
Post-infectious Anti-GFAP-associated meningoencephalitis: A case report
-
Post-stroke dystonia: Three unique cases
-
Post-Traumatic Stress Disorder and risk of Parkinson’s Disease– 20 Years Follow-up real world data analysis
-
Potential drug-drug interactions in hospitalized patients with Parkinson’s disease from tertiary center in Serbia
-
Prasinezumab reduced progression of Parkinson’s disease motor features measured by Roche PD Mobile Application v2 sensor features: PASADENA Phase II Part 1
-
Precision Medicine in Neurodegeneration associated with Pantothenate kinase (PKAN) , its possible?
-
Predicting MDS-UPDRS Ratings for Deep Brain Stimulation Patients Using Wearable Sensor Data
-
Predictive factors of LCIG infusion therapy adherence – a single-center study of 103 consecutive LCIG patients
-
Predictive value of UPSIT subsets in prodromal Parkinson disease
-
Predictors of antidepressant and benzodiazepine treatment in Parkinson’s disease
-
Predictors of Clinically Significant Quality of Life Impairment in Parkinson´s Disease. Results from the COPPADIS Cohort at 2 Years Follow-up.
-
Predictors of Persistence to Deutetrabenazine Among Patients With Tardive Dyskinesia (TD) and Huntington’s Disease (HD)
-
Predictors of survival in Progressive Supranuclear Palsy in a Tunisian cohort
-
Preliminary validation of an educational handbook for Parkinson’s disease patients in Brazil
-
Preoperative EEG-based Machine Learning predicts cognitive deterioration after STN DBS in Parkinson’s Disease patients
-
Prevalence and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in a Large Canadian Cohort from Ontario
-
Prevalence of advanced Parkinson’s disease in Thai patients with Parkinson’s disease using The Consensus on the Definition of Advance Parkinson’s disease (CEPA Study): A single-center study
-
Prevalence of Essential Tremors in Rural Gujarat, India
-
PREVALENCE OF MOVEMENT DISORDERS AT A TERTIARY HEALTH CARE CENTRE IN ABUJA, NIGERIA
-
Prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative cohort.
-
Prevalence of Parkinsonism and Parkinson Disease in urban and rural populations in Latin America.
-
Prevalence of Restless Legs Syndrome in the South African population
-
Prevalence of Suicidal Ideation and Associated Clinical Features in Lewy Body Dementia
-
Preventing falls in Parkinson’s disease by re-educating reactive and planned foot placement accuracy through a multi-sensory approach. 3 cases.
-
Primary Palliative Care for Huntington Disease
-
Problems faced by Parkinson’s disease patients during COVID-19 pandemic compulsory lockdown and its management with the help of Telemedicine in a North Indian cohort
-
Prognostic Modeling of Parkinson’s Disease Progression Using Early Longitudinal Patterns of Change
-
Progression of brain atrophy in Parkinson’s disease is shaped by connectome and local vulnerability
-
Progression of neuroinflammation in patients with isolated REM sleep behavior disorder. A 11C-PK11195 PET study
-
Progression of nigro-striatal denervation in cerebellar Multiple System Atrophy: a prospective study
-
Progression of nigrostriatal dysfunction in Parkinson’s disease: a longitudinal multimodal PET study
-
Progression of Syndrome Specific Metabolic Brain Patterns in Patients with Various Parkinsonian Syndromes
-
Progressive and delayed onset hyperglycemic chorea after blood glucose normalization: A case report
-
Progressive Ataxia with Palatal Tremor in a Metal Worker with Possible Osmotic Demyelination
-
Progressive changes in laryngeal posturing and dynamics as biomarkers of progression in Parkinson’s disease
-
Progressive encephalomyelitis with rigidity and myoclonus in a Mexican patient
-
Progressive Gait Disturbance presumed to be caused by idiopathic peripheral neuropathy: A case of Normal Pressure hydrocephalus.
-
Promising Biomarkers for Task Specific Dystonia
-
Proof-of-concept study testing bevantolol (SOM3355) as treatment of chorea in Huntington’s disease
-
PROPRIOSPINAL MYOCLONUS ASSOCIATED TO SARS-COV-2 RESPIRATORY INFECTION
-
Providing Genetic Testing and Genetic Counseling to the Parkinson’s Disease Community: the PD GENEration Pilot Study Experience
-
PSYCHODYNAMIC THERAPY GROUPS FOR RELATIVES AND CAREGIVERS IN THE CONTEXT OF A PD PROGRAM
-
Psychogenic movement disorders precipitated by post-lockdown return to school in adolescents: case series from Kenya
-
Pyramidal pathway changes at conventional brain 3T-MRI in patients with hereditary spastic paraplegia
MDS Virtual Congress 2021
September 17-22, 2021. Virtual Congress. www.mdscongress.org